We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Saturday
May 13
16:45 - 17:45
Plenary Hall
Palliation - Oligometastases
Mateusz Spałek, Poland;
Vincent Khoo, United Kingdom
Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.
Proffered Papers
Clinical
16:55 - 17:05
Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis. A non-inferiority Trial.
Daniel Rivas, Spain
OC-0266
17:05 - 17:15
Long-term results of an SBRT dose-escalation trial for bone and lymph node metastases (NCT03486431)
Carole Mercier, Belgium
OC-0267
17:15 - 17:25
Should OARs be prioritized in SABR for oligometastases? A secondary analysis of the SABR-5 trial
Reno Eufemon Cereno, Canada
OC-0268
17:25 - 17:35
Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare cohort
Filippo Alongi, Italy
OC-0269
17:35 - 17:35
Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations
Stephanie Kroeze, Switzerland
OC-0270
17:35 - 17:45
SBRT for spine metastases: A systematic review for preparation of an ESTRO practice guideline
Ricarda Stella Guninski, Switzerland
OC-0271